Trials / Completed
CompletedNCT04143750
The Mass Balance and Biotransformation of [14C] Vicagrel in Healthy Man
The Mass Balance and Biotransformation Study of [14C] Vicagrel in Chinese Healthy Adult Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Jiangsu vcare pharmaceutical technology co., LTD · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This study was designed to evaluate the mass balance and biotransformation after single-dose of \[14C\]Vicagrel orally in Chinese healthy male volunteers, revealing the overall pharmacokinetic characteristics of vicagrel in humans, and providing a reference for the rational administration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | [14C]Vicagrel | Take a suspension of 20 mg vicagrel ,containing about 120 μCi \[14C\]Vicagrel, in fasting within 5 minutes |
Timeline
- Start date
- 2019-11-11
- Primary completion
- 2019-12-29
- Completion
- 2020-01-14
- First posted
- 2019-10-29
- Last updated
- 2020-04-03
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04143750. Inclusion in this directory is not an endorsement.